Literature DB >> 31247380

Microporous scaffolds support assembly and differentiation of pancreatic progenitors into β-cell clusters.

Richard L Youngblood1, Joshua P Sampson1, Kimberly R Lebioda1, Lonnie D Shea2.   

Abstract

Human pluripotent stem cells (hPSCs) represent a promising cell source for the development of β-cells for use in therapies for type 1 diabetes. Current culture approaches provide signals to mimic a temporal control of organogenesis to drive the differentiation towards β-cells. However, spatial control may represent an opportunity to improve the efficiency and manufacturing of β-cells. Herein, we adapted the current culture systems to microporous biomaterials with the hypothesis that the pores can guide the assembly of pancreatic progenitors into clusters of defined size that can influence maturation. The scaffold culture allowed hPSC-derived pancreatic progenitors to form clusters at a consistent size as cells differentiated. By modulating the scaffold pore sizes, we observed 250-425 µm pore size scaffold cultures augmented insulin expression and key β-cell maturation markers compared to cells cultured in suspension. Furthermore, when compared to suspension cultures, the scaffold culture showed increased insulin secretion in response to glucose stimulus indicating the development of functional β-cells. In addition, scaffolds facilitated cell-cell interactions enabled by the scaffold design and supported cell-mediated matrix deposition of extracellular matrix (ECM) proteins associated with the basement membrane of islet cells. We further investigated the influence of ECM on cell development by incorporating an ECM matrix on the scaffold prior to cell seeding; however, their presence did not further enhance maturation. These results suggest the microporous scaffold culture provides a conducive environment that drives in vitro differentiation of hPSC-derived insulin-producing glucose-responsive β-cells and demonstrates the feasibility of these scaffolds as a biomanufacturing platform. STATEMENT OF SIGNIFICANCE: Cell therapy for diabetes is a promising strategy, yet generating limitless insulin-producing mature β-cells from human pluripotent stem cells (hPSCs) remains a challenge. Current hPSC differentiation methods involve media containing signals to drive maturation toward β-cells and spontaneous cluster formation. Herein, we sought to provide spatial cues to guide assembly of cells into 3D structures by culture within the pores of a microporous scaffold. The scaffolds direct cell-cell interactions within the pores and provide a support for cell-mediated matrix deposition that collectively creates a niche to promote functional hPSC-derived β-cell clusters. These scaffolds for 3D culture may contribute to hPSC differentiation methods for the generation of β-cells that can treat patients with diabetes.
Copyright © 2019 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biomaterials; Diabetes; Medicine; Regenerative; Stem cell culture

Year:  2019        PMID: 31247380      PMCID: PMC6717676          DOI: 10.1016/j.actbio.2019.06.032

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  63 in total

1.  Small molecules induce efficient differentiation into insulin-producing cells from human induced pluripotent stem cells.

Authors:  Yuya Kunisada; Noriko Tsubooka-Yamazoe; Masanobu Shoji; Masaki Hosoya
Journal:  Stem Cell Res       Date:  2011-10-11       Impact factor: 2.020

2.  Vascularized and functional human liver from an iPSC-derived organ bud transplant.

Authors:  Takanori Takebe; Keisuke Sekine; Masahiro Enomura; Hiroyuki Koike; Masaki Kimura; Takunori Ogaeri; Ran-Ran Zhang; Yasuharu Ueno; Yun-Wen Zheng; Naoto Koike; Shinsuke Aoyama; Yasuhisa Adachi; Hideki Taniguchi
Journal:  Nature       Date:  2013-07-03       Impact factor: 49.962

3.  Superiority of small islets in human islet transplantation.

Authors:  Roger Lehmann; Richard A Zuellig; Patrick Kugelmeier; Philipp B Baenninger; Wolfgang Moritz; Aurel Perren; Pierre-Alain Clavien; Markus Weber; Giatgen A Spinas
Journal:  Diabetes       Date:  2007-03       Impact factor: 9.461

4.  E-cadherin and cell adhesion: a role in architecture and function in the pancreatic islet.

Authors:  Gareth J Rogers; Matthew N Hodgkin; Paul E Squires
Journal:  Cell Physiol Biochem       Date:  2007

5.  Effect of pore size on ECM secretion and cell growth in gelatin scaffold for articular cartilage tissue engineering.

Authors:  Sio-Mei Lien; Liang-Yu Ko; Ta-Jen Huang
Journal:  Acta Biomater       Date:  2008-10-10       Impact factor: 8.947

6.  An autologous cartilage tissue implant NeoCart for treatment of grade III chondral injury to the distal femur: prospective clinical safety trial at 2 years.

Authors:  Dennis C Crawford; Chelsea M Heveran; W Dilworth Cannon; Li Foong Foo; Hollis G Potter
Journal:  Am J Sports Med       Date:  2009-05-15       Impact factor: 6.202

7.  Generation of insulin-producing islet-like clusters from human embryonic stem cells.

Authors:  Jianjie Jiang; Melinda Au; Kuanghui Lu; Alana Eshpeter; Gregory Korbutt; Greg Fisk; Anish S Majumdar
Journal:  Stem Cells       Date:  2007-05-17       Impact factor: 6.277

8.  Microporous Polymer Scaffolds for the Transplantation of Embryonic Stem Cell Derived Pancreatic Progenitors to a Clinically Translatable Site for the Treatment of Type I Diabetes.

Authors:  Tadas Kasputis; Daniel Clough; Fallon Noto; Kevin Rychel; Briana Dye; Lonnie D Shea
Journal:  ACS Biomater Sci Eng       Date:  2018-04-17

9.  Multicenter Australian trial of islet transplantation: improving accessibility and outcomes.

Authors:  P J O'Connell; D J Holmes-Walker; D Goodman; W J Hawthorne; T Loudovaris; J E Gunton; H E Thomas; S T Grey; C J Drogemuller; G M Ward; D J Torpy; P T Coates; T W Kay
Journal:  Am J Transplant       Date:  2013-05-13       Impact factor: 8.086

10.  Immune antibody monitoring predicts outcome in islet transplantation.

Authors:  A M James Shapiro
Journal:  Diabetes       Date:  2013-05       Impact factor: 9.461

View more
  7 in total

Review 1.  Towards systems tissue engineering: Elucidating the dynamics, spatial coordination, and individual cells driving emergent behaviors.

Authors:  Matthew S Hall; Joseph T Decker; Lonnie D Shea
Journal:  Biomaterials       Date:  2020-06-14       Impact factor: 12.479

Review 2.  Integration of Islet/Beta-Cell Transplants with Host Tissue Using Biomaterial Platforms.

Authors:  Daniel W Clough; Jessica L King; Feiran Li; Lonnie D Shea
Journal:  Endocrinology       Date:  2020-11-01       Impact factor: 4.736

3.  Regulation of adipose tissue inflammation and systemic metabolism in murine obesity by polymer implants loaded with lentiviral vectors encoding human interleukin-4.

Authors:  Richard Youngblood; Carmen G Flesher; Jennifer Delproposto; Nicki A Baker; Christopher K Neeley; Fanghua Li; Carey N Lumeng; Lonnie D Shea; Robert W O'Rourke
Journal:  Biotechnol Bioeng       Date:  2020-08-18       Impact factor: 4.530

Review 4.  Islet organoid as a promising model for diabetes.

Authors:  Xiaofei Zhang; Zhuo Ma; Eli Song; Tao Xu
Journal:  Protein Cell       Date:  2021-03-10       Impact factor: 14.870

Review 5.  The progress of pluripotent stem cell-derived pancreatic β-cells regeneration for diabetic therapy.

Authors:  Xin Wang; Mengxi Gao; Yali Wang; Yucheng Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-28       Impact factor: 6.055

Review 6.  Small Molecule-Induced Pancreatic β-Like Cell Development: Mechanistic Approaches and Available Strategies.

Authors:  Gitika Thakur; Hyeon-Jeong Lee; Ryoung-Hoon Jeon; Sung-Lim Lee; Gyu-Jin Rho
Journal:  Int J Mol Sci       Date:  2020-03-30       Impact factor: 5.923

Review 7.  Design Considerations for Macroencapsulation Devices for Stem Cell Derived Islets for the Treatment of Type 1 Diabetes.

Authors:  Debkalpa Goswami; Daniel A Domingo-Lopez; Niamh A Ward; Jeffrey R Millman; Garry P Duffy; Eimear B Dolan; Ellen T Roche
Journal:  Adv Sci (Weinh)       Date:  2021-06-21       Impact factor: 16.806

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.